Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q1- Text added to 2021 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
ABRAXANE, alopecia, Antidilutive, apoptotic, appetite, area, assay, bioavailability, biomarker, burden, CDA, chemical, cohort, compound, confirming, correction, Cytidine, cytosine, dCK, death, deficiency, deliver, diagnosed, DNA, employment, equation, European, exploratory, fatigue, flexibility, Food, free, gemcitabine, Gemzar, Hong, hope, intracellularly, killing, Kong, lung, Macau, median, medicine, mentioned, mouse, MTD, NaN, nucleoside, Ocuphire, persisting, Pharma, pharmacokinetic, phosphorylated, precision, Preliminary, rash, recession, refining, relapsed, Republic, resistance, resistant, RNA, scan, Schedule, screening, Secondary, shelf, shorter, shrinkage, Singapore, spectrum, stable, structure, summary, Taiwan, track, transportation, undertaken, urgent
Removed:
April, closeout, controlled, dividend, entitled, investor, lock, partial, provision, ratchet, recruiting, relation
Valuein 2021 Q1 filing- Value in 2021 Q2 filing
Original filings
Filing view